Bioactive cells, medications, and proteins can be integrated to create human-specific implants, which is driving the advancement of 3D printing technology in the pharmaceutical and medical industries. Using the additive manufacturing process of 3D printing, materials like plastic, liquids, metal, ceramics, live cells, and polymers are continuously deposited to create three-dimensional items. These days, 3D printing is mostly utilized in the production of surgical instruments, dental implants, and intricate replacements for interior body parts.

3D printing in the medical profession allows for the direct creation of patient-specific products from CAD images, including implants, hearing aids, bone scaffolds, and surgical equipment. Patients recover more quickly, surgical success rates rise, and expenses are reduced as a result of these customized solutions. Standard implants frequently do not meet patient needs, particularly in neurosurgery, where cranial implants are challenging due to the uneven and unique shape of each human skull. Physicians are able to plan elective surgical treatments, particularly those that are difficult to execute, with the use of a 3D-printed patient-specific model. These models enhance the quality of patient care and therapy while optimizing procedure time. Therefore, the application of 3D printing technology in the creation of intricate and personalized prosthetic limbs, surgical implants, and brain designs.

However, Strict regulatory requirements, particularly in the US, are a significant barrier impeding the market's expansion for 3D printed medical products. It takes three to seven years in the US to demonstrate a new device's safety for medical use. Even a resized version of a product that has already received approval from the government must follow all legal procedures before being sold. When a corporation manufactures a customized product or gadget, it must go through a drawn-out procedure wherein each component of the item must be separately examined and certified. The FDA approves simple 3D-printed devices, but complicated devices that must meet numerous FDA regulations are a barrier to the widespread use of 3D-printed goods. 

Amidst the COVID-19 pandemic in 2020, the global market for 3D printing medical devices experienced a notable deceleration in growth as a result of the disturbance in the medical device supply chain network and the temporary suspension of 3D printing medical device production in North America. However, the start of widespread immunization campaigns in 2021 removed the travel ban and lockdown, allowing manufacturing facilities to reopen and increasing demand for medical devices—including 3D printed ones. 

The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Autodesk Inc, Biomerics LLC,  Desktop Metal Inc, EOS GmbH, General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., Medtronic Plc, Qualtech Consulting Corp. and Stratasys Ltd.  

By Component: Based on the Component, Global 3D Printing Medical Devices Market is segmented as; 3D Bioprinter, 3D Printer, Material Software, Service.

By Application: Based on the Application, Global 3D Printing Medical Devices Market is segmented as; Implant, Prosthetics and Surgical Guides.  

By End User: Based on the End User, Global 3D Printing Medical Devices Market is segmented as; Hospitals and Research Centres.

By Technology: Based on the Technology, Global 3D Printing Medical Devices Market is segmented as; DLP, DLMS, EBM, Polyjet, SLS, SLA.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.